RxDoctor Payments Data

Megan Monnier, NP

Gerontology · Bloomington, INNPI 1639694409

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 61.1% of it on its own, with 14 other manufacturers making up the rest. Among gerontology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,891in general payments, 2019–2025

Across 286 payments — averaging $80.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$14K
  • Medtronic$5K
  • Boston Scientific$3K
  • Cardiva Medical, Inc.$125
  • Abiomed$91
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$70
  • plus $306 from 9 others

What the payments were for

  • Consulting fees$5252%
  • Speaking & faculty fees$2,0009%
  • Travel & lodging$11,73551%
  • Food & beverage$8,47237%
  • Education$1601%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,891 in reported general payments places this provider in the 95th percentile of 230 gerontology providers in Indiana.

See all gerontology providers in Indiana

Medicare billing

Part B allowed, 2024
$35,448
Medicare patients
268
Services billed
469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$107,908
EntrestoSacubitril/Valsartan23$17,916
Repatha SureclickEvolocumab11$13,646
XareltoRivaroxaban12$8,617
Flecainide Acetate27$2,380
Metoprolol Succinate99$1,079
ClopidogrelClopidogrel Bisulfate66$724
Atorvastatin Calcium52$623
Carvedilol60$483
Losartan Potassium36$471
Valsartan16$445
Potassium Chloride40$430
Amiodarone Hcl25$372
Amlodipine Besylate51$368
Torsemide21$286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$56$107,908129 claims
NovartisEntresto$57$17,91623 claims
Johnson & JohnsonXarelto$11$8,61712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 230 gerontology providers in Indiana.

Other gerontology in Bloomington

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →